A simple consensus approach improves somatic mutation prediction accuracy

Genome Medicine

Volumn 5, Issue 9, 2013, Pages

  Goode, David L ^a,c   Hunter, Sally M ^a   Doyle, Maria A ^a   Ma, Tao ^a,c   Rowley, Simone M ^a   Choong, David ^a   Ryland, Georgina L ^a,b   Campbell, Ian G ^a,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; EXOME; FALSE POSITIVE RESULT; FEMALE; GENE FREQUENCY; GENETIC ALGORITHM; GENETIC VARIABILITY; GERM LINE; HUMAN; OVARY TUMOR; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE VARIANT; SOMATIC MUTATION;

EID: 84885356115     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm494     Document Type: Article

References (37)

1. Liu X, Wang J, Chen L. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. Cancer Lett 2012,
2. Shah SP, Roth A, Goya R, Oloumi A, Ha G, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
3. Cancer T, Atlas G. Comprehensive molecular portraits of human breast tumors. Nature 2012, 490:61-70. 10.1038/nature11412, 3465532, 23000897.
4. Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, et al. RNF43 is a tumor suppressor gene mutated in mucinous tumors of the ovary. J Pathol 2013, 229:469-476. 10.1002/path.4134, 23096461.
5. Kumar A, White TA, MacKenzie AP, Clegg N, Lee C, et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A 2011, 108:17087-17092. 10.1073/pnas.1108745108, 3193229, 21949389.
6. Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet 2012, 44:1310-1315. 10.1038/ng.2455, 3515204, 23104009.
7. Roth A, Ding J, Morin R, Crisan A, Ha G, et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumor paired next-generation sequencing data. Bioinformatics (Oxford, England) 2012, 28:907-913.
8. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013, 31:1-9.
9. Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics (Oxford, England) 2012, 28:311-317.
10. Pabinger S, Dander A, Fischer M, Snajder R, Sperk M, Pabinger S, Dander A, Fischer M, Snajder R, Sperk M, et al. A survey of tools for variant analysis of next-generation genome sequencing data. Briefings Bioinformat 2013,
11. Gerstung M, Beisel C, Rechsteiner M, Wild P, Schraml P, et al. Reliable detection of subclonal single-nucleotide variants in tumor cell populations. Nat Communications 2012, 3:811.
12. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012, 30:413-421. 10.1038/nbt.2203, 22544022.
13. Van Loo P, Nordgard SH, Lingjærde OC, Russnes HG, Rye IH, et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010, 107:16910-16915. 10.1073/pnas.1009843107, 2947907, 20837533.
14. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011, 43:491-498. 10.1038/ng.806, 3083463, 21478889.
15. Goya R, Sun MGF, Morin RD, Leung G, Ha G, et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics (Oxford, England) 2010, 26:730-736.
16. Wendl MC, Wallis JW, Lin L, Kandoth C, Mardis ER, et al. PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics (Oxford, England) 2011, 27:1595-1602.
17. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011, 39:D945-D950. 10.1093/nar/gkq929, 3013785, 20952405.
18. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890, Cancer Genome Atlas Research Network.
19. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510. 10.1038/nature10738, 3267864, 22237025.
20. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, et al. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 1996, 56:719-721.
21. Merritt MA, Green AC, Nagle CM, Webb PM, Australian Cancer Study (Ovarian Cancer): Australian Ovarian Cancer Study Group Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 2008, 122:170-176. 10.1002/ijc.23017, 17721999, Australian Cancer Study (Ovarian Cancer): Australian Ovarian Cancer Study Group.
22. Hunter SM, Gorringe KL, Christie M, Rowley SM, Bowtell DD, et al. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations. Clin Cancer Res 2012, 18:5267-5277. 10.1158/1078-0432.CCR-12-1103, 22891197.
23. http://picard.sourceforge.net.
24. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics (Oxford, England) 2009, 25:2078-2079.
25. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010, 20:1297-1303. 10.1101/gr.107524.110, 2928508, 20644199.
26. Mutect. http://www.broadinstitute.org/cancer/cga/MuTect.
27. JointSNVMix. http://compbio.bccrc.ca/software/jointsnvmix.
28. SomaticSniper. https://github.com/genome/somatic-sniper.
29. R Core Team R: A Language and Environment for Statistical Computing 2012, Vienna, Austria: R Foundation for Statistical Computing, 3-900051-07-0, URL http://www.R-project.org/, R Core Team.
30. Flicek P, Amode MR, Daniel Barrell D, Kathryn Beal K, Simon Brent S, et al. Ensembl 2012. Nucleic Acids Res 2012, 40:D84-D90. 10.1093/nar/gkr991, 3245178, 22086963.
31. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England) 2009, 25:1754-1760.
32. Tsiatis AC, Norris-Kirby A, Rich RG, Hafez MJ, Gocke CD, et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mole Diagn: JMD 2010, 12:425-432.
33. Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 2008, 11:1851-1858.
34. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science (New York, NY) 2012, 337:64-69.
35. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073. 10.1038/nature09534, 3042601, 20981092.
36. Ding J, Bashashati A, Roth A, Oloumi A, Tse K, et al. Feature-based classifiers for somatic mutation detection in tumor-normal paired sequencing data. Bioinformatics (Oxford, England) 2012, 28:167-175.
37. Löwer M, Renard BY, de Graaf J, Wagner M, Paret C, et al. Confidence-based somatic mutation evaluation and prioritization. PLoS Comput Biol 2012, 8:e1002714. 10.1371/journal.pcbi.1002714, 3459886, 23028300.